Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma

NCT05759312 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Clear Cell Carcinoma

Interventions

DRUG: Zimberelimab
DRUG: Metformin Hydrochloride

Sponsor

Fudan University